The Use of Genex in the Management of Early-Stage Osteonecrosis of the Femoral Head
(Genex Trial)

Recruiting in Palo Alto (17 mi)

Overseen byNicolas Piuzzi

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: The Cleveland Clinic

No Placebo Group

Trial Summary

What is the purpose of this trial?

The purpose of this study is to assess the clinical and x-ray results of patients who are treated with core decompression of the hip and the injection of a bone marrow concentrate and the use of the Bone Graft Substitute Genex®.

Research Team

Nicolas Piuzzi

Principal Investigator

The Cleveland Clinic

Eligibility Criteria

Inclusion Criteria

Subject must be physically and mentally willing and able, in the Investigator's opinion at the time of enrollment, to be compliant with the protocol and complete the study protocol and follow ups

Subject is at least 18 years or older with osteonecrosis of the femoral head

Surgeon considers the patient appropriate for the core decompression procedure of the hip

See 1 more

Treatment Details

Interventions

Genex (Bone Graft Substitute)

Participant Groups

1Treatment groups

Experimental Treatment

Group I: Genex with ABMCExperimental Treatment1 Intervention

Injection of autologous bone marrow concentrate and the use of genex® Bone graft Substitute as an adjunct associated with the Core decompression procedure